* Sotera Health Co SHC.OQ SHC.O is expected to show a
rise in
quarterly revenue when it reports results on August 5 for the
period ending June 30 2024
* The Broadview Heights Ohio-based company is expected to
report
a 4.4% increase in revenue to $266.443 million from $255.28
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Sotera Health Co is for
earnings of 16 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sotera
Health Co
is $15.25, above its last closing price of $13.63.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.13 0.13 0.13 Met 4
Jan. 1 2024 0.26 0.26 0.26 Met 0.9
Jan. 1 0001 0.20 0.20 0.21 Beat 6.2
Jan. 1 0001 0.17 0.18 0.21 Beat 14.1
Jan. 0.14 0.14 0.13 Missed -4.5
1 0001
Dec. 31 2022 0.22 0.22 0.25 Beat 14.1
Sep. 30 2022 0.22 0.22 0.23 Beat 2.8
Jan. 1 0001 0.24 0.24 0.27 Beat 11.3
This summary was machine generated August 2 at 15:09 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)